Steatohepatitis and Fibrosis Influence the Occurrence of Type 2 Diabetes Mellitus during the Follow-up in Non-Diabetic Biopsy-Proven NAFLD Patients

被引：0
|
作者：
Ampuero, Javier [1 ]
Aller-De La Fuente, Rocio [2 ]
Gallego-Duran, Rocio [1 ]
Banales, Jesus [3 ]
Crespo, Javier [4 ]
Garcia-Monzon, Carmelo [5 ]
Luis Calleja, Jose [6 ]
Gomez-Camarero, Judith [7 ]
Iacono, Oreste L. O. [8 ]
Escudero-Garcia, Desamparados [9 ]
Albillos, Agustin [10 ]
Javier Garcia-Samaniego, Francisco [11 ]
Jorquera, Francisco [12 ]
Fernandez-Rodriguez, Conrado M. [13 ]
Caballeria, Juan [9 ]
Frances, Ruben [14 ]
Diago, Moises [15 ]
Romero-Gomez, Manuel [16 ,17 ]
机构：
[1] Univ Seville, CSIC, Hosp Univ Virgen Del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain
[2] Univ Valladolid, Valladolid, Spain
[3] Univ Basque Country UPV EHU, Donostia Univ Hosp, Biodonostia Hlth Res Inst, Ikerbasque, Leioa, Spain
[4] Marques De Valdecilla Univ Hosp, Hepatol Unit, Idival, Santander, Spain
[5] Hosp Univ Santa Cristina, Madrid, Spain
[6] Univ Autonoma Madrid, Madrid, Spain
[7] Hosp Univ Burgos, Burgos, Spain
[8] Hosp Univ Tajo, Madrid, Spain
[9] Hosp Clin Barcelona, Barcelona, Spain
[10] Ramon & Cajal Inst Hlth Res, Catedrat Med, Madrid, Spain
[11] Hosp Univ La Paz, Hepatol Unit, Madrid, Spain
[12] Hosp Univ, Madrid, Spain
[13] Hosp Univ Fdn Alcorcon, Alcorcon, Spain
[14] Umh, Med, Elche, Spain
[15] Univ Valencia, Valencia, Spain
[16] Virgen Del Rocio Univ Hosp, IBIS, Digest Dis Dept, Seville, Spain
[17] Virgen Del Rocio Univ Hosp, Ciberehd, Seville, Spain
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1671
引用
收藏
页码：950A / 951A
页数：2
相关论文
共 50 条
  • [1] The Performance of the NAFLD Fibrosis Score in Hispanics With Type 2 Diabetes and Biopsy-Proven NAFLD
    Barbara, Mary
    Annunziata, Giuseppe
    Noureddin, Mazen
    Alkhouri, Naim
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S578 - S578
  • [2] HIGH RATE OF BIOPSY-PROVEN ADVANCED FIBROSIS AMONG TYPE 2 DIABETES PATIENTS SCREENED FOR NAFLD IN DIABETES UNITS
    Castera, Laurent
    Vidal-Trecan, Tiphaine
    Pichard, Anais Vallet
    Gault, Nathalie
    Paradis, Valerie
    Czernichow, Sebastien
    Terris, Benoit
    Manchon, Pauline
    Boitard, Christian
    Roulot-Marullo, Dominique
    Bihan, Helene
    Poynard, Thierry
    Brustowsky, Angelique
    Larger, Etienne
    Pol, Stanislas
    Bedossa, Pierre
    Laouenan, Cedric
    Gautier, Jean-Francois
    Valla, Dominique Charles
    HEPATOLOGY, 2021, 74 : 1017A - 1017A
  • [3] Kidney Biopsy-Proven Diabetic and Non-Diabetic Kidney Diseases and Outcomes in Patients With Type 2 Diabetes Receiving Dialysis: The REIN Registry
    Ingwiller, Maxime
    Delautre, Arnaud
    Tivollier, Jean-Michel
    Edet, Stephane
    Florens, Nans
    Couchoud, Cecile
    Hannedouche, Thierry
    KIDNEY MEDICINE, 2025, 7 (02)
  • [4] Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD
    Onnerhag, Kristina
    Nilsson, Peter M.
    Lindgren, Stefan
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (09) : 1111 - 1118
  • [5] Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis
    Seko, Yuya
    Nishikawa, Taichiro
    Umemura, Atsushi
    Yamaguchi, Kanji
    Moriguchi, Michihisa
    Yasui, Kohichiroh
    Kimura, Mayumi
    Iijima, Hiroaki
    Hashimoto, Toshio
    Sumida, Yoshio
    Okanoue, Takeshi
    Itoh, Yoshito
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2018, 11 : 835 - 843
  • [6] Anthropometry, Metabolic Control, and Follow-Up in Children and Adolescents with Type 1 Diabetes Mellitus and Biopsy-Proven Celiac Disease
    Froehlich-Reiterer, Elke E.
    Kaspers, Stefan
    Hofer, Sabine
    Schober, Edith
    Kordonouri, Olga
    Pozza, Susanne Bechtold-Dalla
    Holl, Reinhard W.
    JOURNAL OF PEDIATRICS, 2011, 158 (04): : 589 - U94
  • [7] Analysis of serum metabolomics among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls
    Tao, Sibei
    Zheng, Wen
    Liu, Yuan
    Li, Ling
    Li, Lingzhi
    Ren, Qian
    Shi, Min
    Liu, Jing
    Jiang, Jing
    Ma, Huichao
    Huang, Zhuo
    Xia, Zijing
    Pan, Jing
    Wei, Tiantian
    Wang, Yan
    Li, Peiyun
    Lan, Tian
    Ma, Liang
    Fu, Ping
    RSC ADVANCES, 2019, 9 (33) : 18713 - 18719
  • [8] FIBROSIS PROGRESSION RATE AMONG DIABETIC VERSUS NON-DIABETIC PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE: A MULTICENTER PROSPECTIVE STUDY
    Huang, Daniel
    Wilson, Laura A.
    Behling, Cynthia
    Kleiner, David E.
    Kowdley, Kris V.
    Dasarathy, Srinivasan
    Terrault, Norah
    Diehl, Anna Mae
    Chalasani, Naga P.
    Tetri, Brent A.
    Sanyal, Arun J.
    Tonascia, James
    Loomba, Rohit
    HEPATOLOGY, 2022, 76 : S10 - S12
  • [9] Time-averaged proteinuria during follow-up and renal prognosis in patients with biopsy-proven benign nephrosclerosis
    Amano, Hoichi
    Koike, Kentaro
    Haruhara, Kotaro
    Tsuboi, Nobuo
    Ogura, Makoto
    Yokoo, Takashi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (08) : 688 - 695
  • [10] Time-averaged proteinuria during follow-up and renal prognosis in patients with biopsy-proven benign nephrosclerosis
    Hoichi Amano
    Kentaro Koike
    Kotaro Haruhara
    Nobuo Tsuboi
    Makoto Ogura
    Takashi Yokoo
    Clinical and Experimental Nephrology, 2020, 24 : 688 - 695
12345